View graph of relations
  1. 2017
  2. Published
  3. Published
  4. Published
    Herukka, S-K., Simonsen, A. H., Andreasen, N., Baldeiras, I., Bjerke, M., Blennow, K., ... Waldemar, G. (2017). Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment. Alzheimer's & Dementia, 13(3), 285-295. DOI: 10.1016/j.jalz.2016.09.009
  5. Published
    Simonsen, A. H., Herukka, S-K., Andreasen, N., Baldeiras, I., Bjerke, M., Blennow, K., ... Waldemar, G. (2017). Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia. Alzheimer's & Dementia, 13(3), 274-284. DOI: 10.1016/j.jalz.2016.09.008
  6. Published
  7. Published
  8. 2016
  9. Published
  10. Published
  11. Published
  12. 2015
  13. Published
  14. 2014
  15. Published
  16. Published
    Wimo, A., Ballard, C., Brayne, C., Gauthier, S., Handels, R., Jones, R. W., ... Kramberger, M. (2014). Health economic evaluation of treatments for Alzheimer's disease: impact of new diagnostic criteria. Journal of Internal Medicine, 275(3), 304-316. DOI: 10.1111/joim.12167
  17. Published
  18. 2013
  19. Published
    Ossenkoppele, R., Prins, N. D., Pijnenburg, Y. A. L., Lemstra, A. W., van der Flier, W. M., Adriaanse, S. F., ... van Berckel, B. N. M. (2013). Impact of molecular imaging on the diagnostic process in a memory clinic. Alzheimer's & Dementia, 9(4), 414-421. DOI: 10.1016/j.jalz.2012.07.003
  20. Published
  21. Published
  22. 2012
  23. Published
  24. Published
  25. 2010
  26. Published